Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.
about
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.A 99mTc-labelled scFv antibody fragment that binds to prostate-specific membrane antigen.Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095.Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelIn Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy.Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer TreatmentPSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responsesBispecific protein targets prostate cancer64Cu-PSMA-617: A novel PSMA-targeted radio-tracer for PET imaging in gastric adenocarcinoma xenografted mice model.Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a 68Ga-THP-scFv targeting the prostate-specific membrane antigen.Low level endogenous prostate-specific membrane antigen (PSMA) expression in non-prostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging.Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine
P2860
Q30354652-848E3918-0DBB-46DE-86D5-999F648CFC46Q30491961-D9D7518D-BA97-453A-8C6C-B56E878073CAQ33581903-9E75DBCA-0526-41E8-BF7C-E8D4E78AD6C4Q38672855-3FEDEC21-AEA8-455B-9ABB-6FCCDD57F78DQ38925590-54F1DD8E-0DA1-4872-AF68-D94E938E9970Q39183360-B88D9BCE-6F22-4CF5-9F17-EFD31F241E0EQ39780216-B784BB62-0F3D-4EBE-B06B-BC349747F0F9Q41475179-CEAF0074-ED28-4644-8689-A68EB99EAB57Q42114642-E54DDB30-C9B8-4A9A-875F-3A7668C970A1Q42335076-F763E78E-350A-4676-8B92-6EAE11460D2EQ42756624-29B4370F-BD5C-4A5B-A776-FEE799CEB736Q44895959-46E0331A-1F09-45C5-A46D-1C8821909A4CQ47105948-E2229171-433B-41B3-84E0-DB1DB8BECEC0Q47808270-F7B4D313-1D5A-45F9-A6F2-DA43C40137D5Q52581725-ECE7A533-5096-42BF-A82D-8C1E71E7CC3DQ57107703-3B44901C-7CBD-4745-B034-EFAA50AD7D7B
P2860
Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Radioimmunotherapy of Metastat ...... Specific Monoclonal Antibody.
@en
type
label
Radioimmunotherapy of Metastat ...... Specific Monoclonal Antibody.
@en
prefLabel
Radioimmunotherapy of Metastat ...... Specific Monoclonal Antibody.
@en
P2093
P1476
Radioimmunotherapy of Metastat ...... Specific Monoclonal Antibody.
@en
P2093
Anastasia Nikolopoulou
David M Nanus
Gurveen Kaur
Neil H Bander
Scott T Tagawa
Shankar Vallabhajosula
Stanley J Goldsmith
Yuliya S Jhanwar
P356
10.2174/1874471008666150313114005
P577
2015-03-13T00:00:00Z